Endowment Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Endowment Wealth Management's LLY Position: Q1 2026 in Review
Endowment Wealth Management reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $22.3K and leaving 765 shares worth $703K. The position accounts for 0.31% of the portfolio, ranked #64.
Endowment Wealth Management first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $846K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Endowment Wealth Management held 765 shares of Eli Lilly worth $703K as of Q1 2026.
- Endowment Wealth Management sold 22 Eli Lilly shares in Q1 2026, an estimated $22.3K.
- Eli Lilly made up 0.31% of Endowment Wealth Management's portfolio in Q1 2026, its #64 holding.
- Endowment Wealth Management first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
- Endowment Wealth Management's Eli Lilly position peaked at $846K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Endowment Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.